Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ADM | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | EXT1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | GRAP | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | OLIG2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | PIGY | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | DNAJC1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
mRNA | TMEM174 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
mRNA | RFTN2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | TSR2 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
mRNA | FAM220A | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |